Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Validation of Pain Assessment Scale Faces Thermometer Scale (FTS)

7 aprile 2022 aggiornato da: Lund University

Validation of Pain Assessment Tool FTS

The aim of the study was to psychometrically evaluate the electronic self assessment Faces Pain Scale (FPS). Validation is performed in relation to golden standard of pain scale assessments Faces Pain Scale Reversed (FPS-R) and Coloured analogue Scale (CAS). 600 children with a range of illnesses on various paediatric healthcare settings in Sweden, Island, Denmark and USA will be included. Pain assessment will take place postoperatively, in relation to procedures or in a setting where acute pain is identified.

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

The Faces Pain Scale-Revised (FPS-R) and Coloured Analogue Scale (CAS), two commonly used analogue pain scales for self-report with good validity and reliability in psychometric evaluations with children 8-17 years of age were used as golden standard for study 1. A systematic review found strong recommendation for the use of FPS-R and CAS for acute pain and weak endorsement for post-operative pain in children above the age of seven9.

Procedure A convenience sample of total of 600 children 8-17 years of age will be enrolled in four groups with 150 children in each group based on a power calculation Group 1: Children with no pain. Group 2: Children experiencing acute pain requiring pain treatment/pain management. Group 3: Children who will undergo medical procedures that are associated with pain, e.g., intramuscular injections, lumbar punctures, and wound care awakening and without strong sedatives. Group 4: Children who will undergo minor surgery. The data collection follows a predetermined study protocol, estimated time for data collection is six to twelve months at each site to fulfil power calculation requisites. Prior to data collection, a pilot study will be done with children (n=20) at Skåne University Hospital and the study protocol will be evaluated for cultural sensitivity with children (n=5) in each country. All assessments will be performed in the child's primary language. In all encounters the words "hurt" or "pain" will be used interchangeably, depending on what seem to be most understandable for each child. The attending nurse/physician will identify eligible study participants and provides the child and the child's caregivers with oral and written information about the study and seeks formal informed consent. The child will be allocated a personal study code. The code also determines the randomized order of pain assessment, i.e., FTS→FPS-R→CAS; CAS→FTS→FPS-R; FPS-R→CAS→FTS which will be used for all assessments by the child to avoid assessment bias. The nurse will present each of the three scales to the child in the same order as assigned to the particular child for the assessment. Data on pain assessment will be collected at specific time points according to which of the four groups it is (Figure 4).

Data from the digital FTS assessment will be transformed by the nurse and documented together with data from FPS-R and CAS into a coded individual paper study form. At all follow- up assessments the child will be asked if he/she experiences more, less, or about the same level of pain as at the previous assessment.

Psychometric properties in terms of validity and reliability of the FTS in relation to the FPS-R and the CAS in our study population will be determined by the use of comparative statistics. Most adequate tests (e.g., Pearson's or Spearman's correlation, regression analysis) will be chosen s depending on data distribution. For group 1 a cut-off score at 0-3 and for group 2 cut-off at 4-10 will be used.

Convergent validity will be assessed by determining correlations and agreement between the FTS, the FPS-R and the CAS for self-assessing pain in children. Discriminative validity (being part of convergent validity) will be assessed to determine to what extent the FTS actually measure only the construct pain, and not something else (e.g., anxiety) by comparing the initial mean FTS, FPS-R, and CAS scores in children with painful conditions, versus those with non-painful conditions. Construct validity (responsivity) in children with painful conditions will be determined by comparing the initial mean FTS, FPS-R, and CAS pain scores with their respective post-treatment pain score. Children with no pain will be assessed in a similar fashion and expect that there should be no difference between the initial and 30-45-minute scores. Reliability (the degree to which pain scores are consistent from one assessment to the next) will be assessed by test-retest analysis in the subgroup of children with painful conditions reporting that their pain is "about the same" both pre- and post-treatment.

Demographic data, e.g., age, sex, native spoken language and ethnicity will be collected through a questionnaire filled out by the child or caregiver. Data on diagnosis, reason for care and information on pain management between assessment one and two, will be collected through a questionnaire in the study form filled out by the nurse. Study forms will be collected from the site by the research group (local PI at each site) and transformed and stored at a secure digital database at Lund University.

Pain assessment will be performed two - four times each with all three scales. Their ratings are documented digitally via the FTS Webb browser on the tablet that provides the scale and by the analogous on a study protocol by the nurse for the two analogue scales. The children provide background data on a questionnaire at baseline. Consecutive sampling will be performed to include another 100 children in 8-17 for evaluation of anticipated pain by the use of the Charleston Paediatric Pain Pictures (CPPP). The child is asked to grade the anticipated level of pain that they associate the illustration on each picture with. The researcher will encourage the child to describe how they reach their decision using a "think-aloud" method. The child's reasoning will be recorded and transcribed verbatim and analysed using a phenomenographic method.

Tipo di studio

Interventistico

Iscrizione (Anticipato)

600

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

      • Linköping, Svezia
        • Reclutamento
        • Universitetssjukhuset i Linköping
        • Contatto:
          • Angelica Höök, RN
      • Lund, Svezia, 22100
        • Reclutamento
        • Skane University Hospital
        • Contatto:
          • Pernilla Stenström, dr, ass prof

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 8 anni a 17 anni (Bambino)

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Children aged 8-17
  • Typically developed child
  • Child and caregiver with the ability to understand spoken Swedish

Exclusion Criteria:

• Children with unstable disease or in need of ICU

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Altro
  • Assegnazione: N / A
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Altro: Validation
Participants are introduced to all three painscales and are asked to rate their pain with each and one of them according to instructions for each scale

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Faces Thermometer Scale validity
Lasso di tempo: Change in pain assessment at up to 4 hours
The Faces Thermometer Scale is a digital pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10. A higher reading indicates higher pain intensity.
Change in pain assessment at up to 4 hours

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Faces Thermometer Scale content validity validity
Lasso di tempo: Change in pain assessment at up to 4 hours
The Faces Thermometer Scale is a digital pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10. A higher reading indicates higher pain intensity.
Change in pain assessment at up to 4 hours
Color Analog Scale validity
Lasso di tempo: Change in pain assessment at 4 hours
The Color Analog Scale is an analog pain measure tool, which allows individuals to rate pain experience on a scale on a continuous scale which for the observer corresponds to a scale from 0 to 10 at intervals of 0.25. A higher reading indicates higher pain intensity.
Change in pain assessment at 4 hours
Faces Pain Scale-Revised validity
Lasso di tempo: Up to 15 min
The Faces Pain Scale-Revised is an analog pain measure tool, which allows individuals to rate pain experience on a scale from 0 to 10 at intervals of 2. A higher reading indicates higher pain intensity.
Up to 15 min

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: charlotte castor, phd, Lund University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

17 settembre 2021

Completamento primario (Anticipato)

1 giugno 2022

Completamento dello studio (Anticipato)

1 dicembre 2022

Date di iscrizione allo studio

Primo inviato

10 novembre 2021

Primo inviato che soddisfa i criteri di controllo qualità

7 aprile 2022

Primo Inserito (Effettivo)

15 aprile 2022

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 aprile 2022

Ultimo aggiornamento inviato che soddisfa i criteri QC

7 aprile 2022

Ultimo verificato

1 aprile 2022

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Altri numeri di identificazione dello studio

  • PR2020-0026

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .